[go: up one dir, main page]

BR102020023560A8 - COMPOSITIONS AND METHODS TO TREAT THE EYES - Google Patents

COMPOSITIONS AND METHODS TO TREAT THE EYES

Info

Publication number
BR102020023560A8
BR102020023560A8 BR102020023560A BR102020023560A BR102020023560A8 BR 102020023560 A8 BR102020023560 A8 BR 102020023560A8 BR 102020023560 A BR102020023560 A BR 102020023560A BR 102020023560 A BR102020023560 A BR 102020023560A BR 102020023560 A8 BR102020023560 A8 BR 102020023560A8
Authority
BR
Brazil
Prior art keywords
compositions
treat
methods
eyes
extracts
Prior art date
Application number
BR102020023560A
Other languages
Portuguese (pt)
Other versions
BR102020023560A2 (en
Inventor
Ting Li Wen-Hwa
Mahmood Khalid
Parsa Ramine
Bai Mingqi
T Holeva Kenneth
Randhawa Manpreet
Original Assignee
Johnson & Johnson Consumer Inc
Johnson & Johnson Surgical Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/099,185 external-priority patent/US11969451B2/en
Application filed by Johnson & Johnson Consumer Inc, Johnson & Johnson Surgical Vision Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR102020023560A2 publication Critical patent/BR102020023560A2/en
Publication of BR102020023560A8 publication Critical patent/BR102020023560A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIÇÃO DE MICROEMULSÃO PARA TRATAMENTO DO OLHO E USO DE UM OU MAIS EXTRATOS, OU FONTES DE ESTRATOS, DO GÊNERO PICHIA OU DA COMPOSIÇÃO. A presente invenção refere-se a composições que compreendem um ou mais compostos e/ou extratos que induzem, promovem e/ou melhoram a produção/liberação/entrega/excreção de ácido hialurônico e/ou mucina a partir de e/ou na córnea, e métodos de uso das composições para tratar o olho.MICROEMULSION COMPOSITION FOR TREATMENT OF THE EYE AND USE OF ONE OR MORE EXTRACTS, OR SOURCES OF STRATA, OF THE GENUS PICHIA OR THE COMPOSITION. The present invention relates to compositions comprising one or more compounds and/or extracts that induce, promote and/or enhance the production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.

BR102020023560A 2019-11-19 2020-11-18 COMPOSITIONS AND METHODS TO TREAT THE EYES BR102020023560A8 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962937473P 2019-11-19 2019-11-19
US201962937458P 2019-11-19 2019-11-19
US62/937,473 2019-11-19
US62/937,458 2019-11-19
US17/099,185 2020-11-16
US17/099,185 US11969451B2 (en) 2019-11-19 2020-11-16 Compositions and methods for treating the eye

Publications (2)

Publication Number Publication Date
BR102020023560A2 BR102020023560A2 (en) 2021-10-13
BR102020023560A8 true BR102020023560A8 (en) 2023-02-07

Family

ID=75964158

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102020023560A BR102020023560A8 (en) 2019-11-19 2020-11-18 COMPOSITIONS AND METHODS TO TREAT THE EYES

Country Status (6)

Country Link
JP (1) JP2021080253A (en)
KR (1) KR20210061297A (en)
CN (1) CN112933118A (en)
AU (2) AU2020273321A1 (en)
BR (1) BR102020023560A8 (en)
CA (1) CA3100032A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117268877B (en) * 2023-11-21 2024-02-20 军科正源（北京）药物研究有限责任公司 Method for detecting nerve growth factor in human tear and method for treating tear

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1883469B (en) * 2006-05-26 2011-07-20 武汉远大制药集团有限公司 An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof
DK2350279T3 (en) * 2008-10-22 2016-02-15 Quark Pharmaceuticals Inc METHODS OF TREATING EYE DISEASES
US20170128357A1 (en) * 2015-11-06 2017-05-11 Johnson & Johnson Consumer Inc. Topical gel cream composition
US20170172913A1 (en) * 2015-12-17 2017-06-22 Johnson & Johnson Consumer Inc. Topical Compositions Comprising Pichia Anomala and Chicory Root Extracts
ITUB20160543A1 (en) * 2016-02-08 2017-08-08 Sooft Italia S P A 63833 Montegiorgio Fermo / Italia STABILIZING OPHTHALMIC AND REINTEGRATED COMPOSITION OF THE LACRIMAL FILM FOR USE IN THE PREVENTION OF VIRAL INFECTIONS
US10206870B2 (en) * 2016-12-12 2019-02-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract

Also Published As

Publication number Publication date
CA3100032A1 (en) 2021-05-19
AU2022263530A1 (en) 2022-12-08
JP2021080253A (en) 2021-05-27
BR102020023560A2 (en) 2021-10-13
CN112933118A (en) 2021-06-11
AU2020273321A1 (en) 2021-06-03
KR20210061297A (en) 2021-05-27

Similar Documents

Publication Publication Date Title
BR112017009807A2 (en) methods and formulations for treating vascular eye diseases
BR112014008789A2 (en) prevention and treatment of eye conditions
MX2018002990A (en) USE OF PASTEURIZED AKKERMANSIA TO TREAT METABOLIC DISORDERS.
BR112015007985A8 (en) use of carbohydrate dentate galactose for the preparation of compositions for treating diabetic nephropathy and associated disorders, and their compositions
BR112017017448A2 (en) Methods and Compositions for the Treatment of Resected Eye Disease and Other Eye Disorders
BR112017009497A2 (en) aadc polynucleotides for the treatment of parkinson's disease
BR112014027571A2 (en) Methods for the treatment of diabetic retinopathy and other eye diseases
MX2017014082A (en) NEW SPECIFIC PROTEINS FOR CD137.
BR112013018920A2 (en) nanoparticle compositions, formulations thereof and their uses
MX2015006234A (en) Use of akkermansia for treating metabolic disorders.
BR112015006093A2 (en) combination of rasagiline and pridopidine for the treatment of neurodegenerative disorders, particularly in huntington's disease
BR112015006623A2 (en) laquinimod and pridopidine for the treatment of neurodegenerative diseases
BR112016013109A2 (en) anti-siglec-8 antibodies and methods of use
BR112015021334A2 (en) Ocular formulations for drug delivery to the posterior segment of the eye
MX369474B (en) TOPICAL COMPOSITIONS INCLUDING AN EXTRACT OF CORIOLUS VERSICOLOR TO INCREASE AUTOIMMUNITY.
MX2016014564A (en) VACCINE AGAINST THE BAUMANNII ACINETOBACTER OBTAINED FROM LENT POLISHING COMPONENTS OF LIPOPOLISACARIDO.
BR112013022094A2 (en) compositions and methods for non-surgical treatment of ptosis
BR112014010376A2 (en) medicament for treating anterior eye disease comprising rebamipide and a tear retention agent
MX383011B (en) HEAT STERILIZED FORMULA INCLUDING CHITOSAN AND PROCESS FOR PREPARING SAME.
BR112018069100A2 (en) a combined vaccine against pcv2 virus infection and mycoplasma hyopneumoniae
BR112017021191A2 (en) an indigo naturalis extract and a process for preparing the same
ECSP22086300A (en) COMPOSITIONS INCLUDING NANOPARTICLES, METHOD OF PREPARATION AND USES THEREOF
BR112017022755A2 (en) glucopyranosyl lipid a and peanut allergen formulations for sublingual administration
BR112016012838A2 (en) COMPOSITION FOR ORAL ADMINISTRATION OF A BIOACTIVE AGENT INCLUDING PARTICLES COMPRISING A BIOACTIVE AGENT AND A MUCOADHESIVE POLYMER IN AN AQUEOUS SOLUTION, AND METHOD OF PREPARING THE COMPOSITION
BR102020023560A8 (en) COMPOSITIONS AND METHODS TO TREAT THE EYES

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON SURGICAL VISION, INC. (US)